SCHEMBL6770449

SCHEMBL6770449

CC(C)c1ccc(-n2nc(Cc3ccccc3)c3c2C(C#N)C(C)(C)CC3=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNA2 P20248 7/20 0.41
CDK2 P24941 7/20 0.41
CYP2C9 P11712 3/20 0.36
CYP2C19 P33261 3/20 0.36
LMNA P02545 3/20 0.36
CYP3A4 P08684 2/20 0.36
ALPL P05186 1/20 0.36
HPGD P15428 1/20 0.36
NPBWR1 P48145 1/20 0.35
MCHR1 Q99705 1/20 0.35
CYP1A2 P05177 2/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP2D6 P10635 1/20 0.33
BCL2 P10415 1/20 0.33
MDM2 Q00987 1/20 0.33
MCL1 Q07820 1/20 0.33
SRC P12931 1/20 0.32
KDM5A P29375 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6771169 0.86 CCNA2 (0.40) CCNA2CDK2CYP2C9CYP2C19LMNA
SCHEMBL6770744 0.86 CYP2C9 (0.38) CCNA2CDK2CYP2C9CYP2C19LMNA
SCHEMBL6766539 0.85 CCNA2 (0.35) CCNA2CDK2CYP2C9CYP2C19LMNA
SCHEMBL6772430 0.84 CCNA2 (0.44) CCNA2CDK2CYP2C9CYP2C19LMNA
SCHEMBL6771265 0.80 CCNA2 (0.40) CCNA2CDK2CYP2C9CYP2C19LMNA
SCHEMBL6771267 0.80 CCNA2 (0.40) CCNA2CDK2CYP2C9CYP2C19LMNA
SCHEMBL6775773 0.79 CCNA2 (0.39) CCNA2CDK2CYP2C9CYP2C19LMNA
SCHEMBL6770739 0.78 CCNA2 (0.45) CCNA2CDK2CYP2C9CYP2C19LMNA
SCHEMBL6776854 0.77 PTGS1 (0.42) CCNA2CDK2CYP2C9CYP2C19LMNA
SCHEMBL6164128 0.77 MEN1 (0.39) CCNA2CDK2CYP2C9CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed